BlackRock, Inc. 13D and 13G filings for Castle Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-23 8:19 pm Sale | 2025-03-31 | 13G | Castle Biosciences, Inc. CSTL | BlackRock Inc. BLK | 2,338,005 8.200% | -706,968 (-23.22%) | Filing |
| 2024-07-08 4:32 pm Purchase | 2024-06-30 | 13G | Castle Biosciences, Inc. CSTL | BlackRock Inc. BLK | 3,044,973 11.000% | 761,774 (+33.36%) | Filing |
| 2024-01-25 1:48 pm Purchase | 2023-12-31 | 13G | Castle Biosciences, Inc. CSTL | BlackRock Inc. BLK | 2,283,199 8.500% | 159,511 (+7.51%) | Filing |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | Castle Biosciences, Inc. CSTL | BlackRock Inc. BLK | 2,123,688 8.100% | 322,301 (+17.89%) | Filing |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Castle Biosciences, Inc. CSTL | BlackRock Inc. BLK | 1,801,387 7.100% | 1,801,387 (New Position) | Filing |